04/22/2024
7:22 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
7:23 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
7:24 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
7:11 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
6:35 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/16/2024
6:32 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
|
04/12/2024
4:04 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
04/09/2024
7:01 AM | Lexeo Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/11/2024
8:29 AM | Lexeo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
3:43 PM | Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
| Form SC 13G | |
02/14/2024
3:34 PM | Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G | |
02/14/2024
12:43 PM | JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:04 AM | D1 Capital Partners L.P. (Filed by)
Lexeo Therapeutics (Subject)
| Form SC 13G | |
02/06/2024
4:56 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:57 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:58 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
4:58 PM | Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:03 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
5:50 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:52 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:00 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
3:51 PM | Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A | |
12/11/2023
6:02 AM | Lexeo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/11/2023
6:03 AM | Lexeo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
3:33 PM | Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G | |
11/09/2023
7:35 PM | Lexeo Therapeutics (Issuer)
McCormac Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:36 PM | Lexeo Therapeutics (Issuer)
Nessi Claudio (Reporting)
Omega Fund VI GP Manager, Ltd. (Reporting)
Omega Fund VI GP, L.P. (Reporting)
Omega Fund VI, L.P. (Reporting)
Paster Anne-Mari (Reporting)
Stampacchia Otello (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:32 PM | ENRIGHT PATRICK G (Reporting)
Lexeo Therapeutics (Issuer)
Longitude Capital Partners IV, LLC (Reporting)
Longitude Venture Partners IV, L.P. (Reporting)
Tammenoms Bakker Juliet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:33 PM | Lexeo Therapeutics (Issuer)
Lundbeckfond Invest A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:13 PM | Lexeo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/02/2023
8:01 PM | Lexeo Therapeutics (Subject)
| Form FWP | |
11/02/2023
11:16 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
11/02/2023
8:37 PM | Lexeo Therapeutics (Issuer)
Lundbeckfond Invest A/S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:38 PM | Lexeo Therapeutics (Issuer)
McCormac Paul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:40 PM | Lexeo Therapeutics (Issuer)
Nessi Claudio (Reporting)
Omega Fund VI GP Manager, Ltd. (Reporting)
Omega Fund VI GP, L.P. (Reporting)
Omega Fund VI, L.P. (Reporting)
Paster Anne-Mari (Reporting)
Stampacchia Otello (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:41 PM | Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:42 PM | Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:36 PM | ENRIGHT PATRICK G (Reporting)
Lexeo Therapeutics (Issuer)
Longitude Capital Partners IV, LLC (Reporting)
Longitude Venture Partners IV, L.P. (Reporting)
Tammenoms Bakker Juliet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:16 PM | Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
11/02/2023
8:17 PM | CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:19 PM | COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:24 PM | Davitian Bernard (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:26 PM | DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:14 PM | Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
8:15 PM | Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/30/2023
5:43 AM | Lexeo Therapeutics (Filer)
| Form S-1/A | |
